OSE Immunotherapeutics SA 6OP.BE
€4.77 €0.00 (0.08%) 1D
Last Updated: Dec 17, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is OSE Immunotherapeutics SA Stock Halal?
Shariah Compliance Analysis of 6OP.BE Stock
Germany Health Care Micro Cap No. As of September 2026, OSE Immunotherapeutics SA (6OP.BE) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. OSE Immunotherapeutics SA does not pass Musaffa's business and financial screening criteria.
OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. The company is headquartered in Nantes, Pays De La Loire and currently employs 68 full-time employees. The company went IPO on 2015-03-30. The company develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The firm's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. The company provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.
6OP.BE Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, OSE Immunotherapeutics SA is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
OSE Immunotherapeutics SA (6OP.BE) Chart
Financial Metrics & Statements of OSE Immunotherapeutics SA (6OP.BE)
FAQ's for OSE Immunotherapeutics SA (6OP.BE)
- As of September 2026, OSE Immunotherapeutics SA 6OP.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes OSE Immunotherapeutics SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in OSE Immunotherapeutics SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of OSE Immunotherapeutics SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of OSE Immunotherapeutics SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of OSE Immunotherapeutics SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for OSE Immunotherapeutics SA (6OP.BE)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
